Spots Global Cancer Trial Database for repaglinide, bupropion and shr3680
Every month we try and update this database with for repaglinide, bupropion and shr3680 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion | NCT04664725 | Prostate Cancer... | Repaglinide, Bu... | 45 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion | NCT04664725 | Prostate Cancer... | Repaglinide, Bu... | 45 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
